{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:44:14Z","timestamp":1775526254779,"version":"3.50.1"},"reference-count":56,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.1080\/14656566.2024.2362902","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T13:05:07Z","timestamp":1717074307000},"page":"915-924","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond"],"prefix":"10.1080","volume":"25","author":[{"given":"Andrew","family":"Gaballa","sequence":"first","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shada","family":"Jadam","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-9797","authenticated-orcid":false,"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.01.019"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc3701.095952"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2020-0242"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072725"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux331"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003132"},{"key":"e_1_3_5_10_1","article-title":"AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"142","author":"Committee Members W","year":"2020","unstructured":"Committee Members W, Ommen SR, Mital S, et al. AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circu [Internet]. 2020 [cited 2024 Feb 1];142. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000938","journal-title":"Circu"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006657"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.06.071"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.35.5.847"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.35.11.1116"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.065"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2022.09.008"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000963"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.1.239"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.27.701"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115061"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.51.5.523"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwac078"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005152"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210143071607"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.012"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-014-0151-5"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-022-00532-x"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1495856"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.776815"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3016"},{"key":"e_1_3_5_31_1","unstructured":"Administration F. Approved drug proucts: CAMZYOS (mavacamten) capsules for oral use [Internet]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214998s000lbl.pdf"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168407"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00763-7"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31792-X"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.5099"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.09.028"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.048"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062534"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014986"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052359"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.3342"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2024.02.001"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.05.007"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2023.06.001"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.090"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016210"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000849"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.027"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.020"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01290"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401424"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.064"},{"key":"e_1_3_5_53_1","unstructured":"Bristol-Myers Squibb. Long-term follow-up data from two phase 3 studies of CAMZYOS (mavacamten) demonstrate consistent and durable response in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). 2023."},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00021.2020"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02190-7"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.3.369"},{"key":"e_1_3_5_58_1","unstructured":"A study of mavacamten in participants with HFpEF and elevation of NT-proBNP with or without elevation of cTnT (EMBARK-HFpEF)."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2362902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T06:03:11Z","timestamp":1727244191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2362902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,2]]}},"alternative-id":["10.1080\/14656566.2024.2362902"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2362902","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}